Latest Media Releases

Investors 1

LEVIN Health reinforces clinical credentials with the major appointments to Medical Advisory Board

LEVIN Health, a leading Australian sports science company focused on evidence-based research, development and commercialisation of a range of medicinal cannabis (MC) products, continues to ready itself for further clinical development with a series of high-profile appointments to its Medical Advisory Board (MAB). LEVIN Health is currently recruiting for its Phase 2a clinical trial investigating… continue reading»

Investors 2

LEVIN Health receives ethics approval for Phase 2a clinical trial for chronic pain

LEVIN Health (“Levin”, or “the Company”), a leading Australian sports science company committed to solving some of the most challenging health issues facing the wider community, has received ethics approval for its Phase 2a clinical trial to evaluate the efficacy of its licensed cannabinoid formulation in treating patients with chronic pain, receiving ethics approval. Undertaken… continue reading»

Contact Us

    *By clicking 'SUBMIT' I agree with Levin Health's Privacy Collection Notice and T&Cs.